1. Home
  2. EFOI vs MYNZ Comparison

EFOI vs MYNZ Comparison

Compare EFOI & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energy Focus Inc.

EFOI

Energy Focus Inc.

N/A

Current Price

$2.05

Market Cap

10.2M

ML Signal

N/A

Logo Mainz Biomed N.V.

MYNZ

Mainz Biomed N.V.

HOLD

Current Price

$0.80

Market Cap

5.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EFOI
MYNZ
Founded
1985
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.2M
5.4M
IPO Year
2004
2021

Fundamental Metrics

Financial Performance
Metric
EFOI
MYNZ
Price
$2.05
$0.80
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
10.9K
262.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,860,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$5.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.43
$0.55
52 Week High
$3.56
$5.54

Technical Indicators

Market Signals
Indicator
EFOI
MYNZ
Relative Strength Index (RSI) 52.97 47.45
Support Level $1.79 $0.57
Resistance Level $2.15 $1.69
Average True Range (ATR) 0.09 0.09
MACD 0.03 0.03
Stochastic Oscillator 57.84 68.48

Price Performance

Historical Comparison
EFOI
MYNZ

About EFOI Energy Focus Inc.

Energy Focus Inc engages in the design, development, manufacturing, marketing, and sale of energy-efficient lighting systems and controls. The company serves the military maritime market and general commercial markets. Its product offerings include Military maritime LED lighting products such as military intelligible, globe lights, berth lights, and military fixtures and Commercial products such as LED fixtures and panels, LED down-lights, LED dock lights, and LED retrofit kits. Geographically, it operates in the United States and other countries. Its products include commercial products and MMM products. The company generates a majority of its sales from Military maritime products in the United States.

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

Share on Social Networks: